Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

被引:11
|
作者
Hung, Tsung-Min [1 ,2 ]
Chen, Chien-Cheng [2 ,3 ]
Lin, Chien-Yu [1 ,2 ]
Ng, Shu-Hang [2 ,3 ]
Kang, Chung-Jan [2 ,4 ]
Huang, Shiang-Fu [2 ,4 ]
Liao, Chun-Ta [2 ,4 ]
Fan, Kang-Hsing [1 ,2 ]
Wang, Hung-Ming [2 ,5 ]
Chang, Joseph Tung-Chieh [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan
关键词
Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Prognosis; Prepontine cistern invasion; Distant metastasis; Intracranial extension; Head and neck cancer; BARR-VIRUS DNA; PHASE-II TRIAL; F-18-FDG PET; EXPERIENCE; CHEMOTHERAPY; CANCER;
D O I
10.1016/j.oraloncology.2013.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the prognostic value of prepontine cistern invasion (PPCI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Materials and methods: Five hundred and four non-disseminated NPC patients who underwent magnetic resonance imaging examination before radical IMRT between November 2000 and December 2008 were retrospectively reviewed. The diagnostic criteria for PPCI were tumor invasion through the posterior cortex of clivus and extension into the prepontine cistern. Results: The median follow-up of the patients in this study was 63.5 months. PPCI was found in 44 patients (25% of T4 patients). The 5-year progression-free survival (PFS), local control (LC), distant metastasis- free survival (DMFS), and overall survival (OS) of all patients, with and without PPCI, were 44.3% and 70.5% (p < 0.001), 84.4% and 89.1% (p = 0.376), 66.6% and 87.3% (p < 0.001), and 59.6% and 80.2% (p < 0.001), respectively. In T4 patients with PPCI and without PPCI, the 5-year PFS, LC, DMFS, and OS were 44.3% and 62.5% (p = 0.023), 84.4% and 84.9% (p = 0.946), 66.6% and 83.1% (p = 0.022), and 59.6% and 71.0% (p = 0.045), respectively. Using multivariate analysis, PPCI was found to be an independent poor prognostic factor for PFS (HR = 1.816; p = 0.007), DMFS (HR = 1.928; p = 0.045), and OS (HR = 1.798; p = 0.016). Conclusion: Prepontine cistern invasion was an independent prognostic factor for poor DMFS and OS but not LC in NPC patients treated with IMRT, even within T4 patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
    Feng, Yanru
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    CANCER RESEARCH AND TREATMENT, 2019, 51 (03): : 1222 - 1230
  • [22] Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Tian, Y-M
    Tian, Y-H
    Zeng, L.
    Liu, S.
    Guan, Y.
    Lu, T-X
    Han, F.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 297 - 303
  • [23] Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (03): : 590 - 595
  • [24] Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Chua, DTT
    Sham, JST
    Leung, LHT
    Au, GKH
    RADIOTHERAPY AND ONCOLOGY, 2005, 77 (03) : 290 - 294
  • [25] Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
    Li, An-Chuan
    Xiao, Wei-Wei
    Wang, Lin
    Shen, Guan-Zhu
    Xu, An-An
    Cao, Yan-Qing
    Huang, Shao-Min
    Lin, Cheng-Guang
    Han, Fei
    Deng, Xiao-Wu
    Zhao, Chong
    TUMOR BIOLOGY, 2015, 36 (11) : 8349 - 8357
  • [26] Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
    Lin, Yun-Hsuan
    Huang, Tai-Lin
    Chien, Chih-Yen
    Chen, Hui-Chun
    Hsu, Hsuan-Chih
    Huang, Eng-Yen
    Wang, Chong-Jong
    Huang, Yu-Jie
    Wang, Yu-Ming
    Huang, Chun-Chieh
    Chou, Shang-Yu
    Liao, Kuan-Cho
    Fang, Fu-Min
    RADIATION ONCOLOGY, 2018, 13
  • [27] The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era
    Tang, Ling-Long
    Liang, Shao-Bo
    Huang, Cheng-Long
    Zhang, Fan
    Xu, Cheng
    Mao, Yan-Ping
    Tian, Li
    Lin, Ai-Hua
    Li, Li
    Sun, Ying
    Ma, Jun
    CANCER MEDICINE, 2019, 8 (05): : 2213 - 2222
  • [28] Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy
    Tang, Linbo
    Li, Xinjing
    Wang, Yongbin
    Tong, Yuanhe
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1321 - 1328
  • [29] Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Wei Lu Kuang
    Qin Zhou
    Liang Fang Shen
    Clinical and Translational Oncology, 2012, 14 : 783 - 790
  • [30] Intensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patients
    Chen, Xiaoqian
    Lei, Hao
    Liang, Zhongguo
    Li, Ling
    Qu, Song
    Zhu, Xiaodong
    SPRINGERPLUS, 2016, 5